Trojano, Maria
Tintore, Mar
Montalban, Xavier
Hillert, Jan
Kalincik, Tomas
Iaffaldano, Pietro
Spelman, Tim
Sormani, Maria Pia
Butzkueven, Helmut
Article History
First Online: 13 January 2017
Competing interests
: Maria Trojano has served on scientific Advisory Boards for Almirall, Biogen, Genzyme, Novartis and Roche; has received speaker honoraria from Almirall, Bayer, Biogen, Genzyme, Merck Serono, Novartis, Sanofi and Teva Pharmaceuticals; and has received research grants for her Institution from Biogen, Merck Serono and Novartis. Mar Tintore has received compensation for consulting services and speaking from Bayer, Biogen, Merck Serono, Novartis, Sanofi and Teva Pharmaceuticals. Xavier Montalban has received speaking honoraria and travel expenses for scientific meetings, has been a steering committee member of clinical trials or participated in advisory boards of clinical trials with Almirall, Bayer, Biogen, Genentech, Genzyme, Merck Serono, Novartis, Sanofi and Teva Pharmaceuticals. Jan Hillert has received honoraria for serving on advisory boards for Biogen, Genzyme and Novartis, and has received speaker's fees from Bayer, Biogen, Genzyme, Merck Serono, Novartis, and Teva Pharmaceuticals. He has served as principal investigator for projects sponsored by, or received unrestricted research support from Bayer, Biogen, Merck Serono, Novartis and Teva Pharmaceuticals. Tomas Kalincik has served on scientific advisory boards for Biogen, Genzyme, Merck, Novartis and Roche; has received conference travel support and/or speaker honoraria from BioCSL, Biogen, Genzyme, Merck, Novartis, Sanofi, Teva Pharmaceuticals and WebMD Global; and has received research support from Biogen. Pietro Iaffaldano has served on scientific advisory boards for Bayer and Biogen, and has received funding for travel and/or speaker honoraria from Biogen, Novartis, Sanofi and Teva Pharmaceuticals. Tim Spelman has received travel support, speaker honoraria and compensation for serving on advisory boards from Biogen and Novartis. Maria Pia Sormani received consulting fees from Biogen, GeNeuro, Genzyme, Merck Serono, Novartis, Roche, Teva Pharmaceuticals and Vertex. Helmut Butzkueven has served on scientific advisory boards for Biogen, Novartis and Sanofi and has received conference travel support from Biogen, Novartis and Sanofi. He serves on steering committees for trials conducted by Biogen and Novartis and has received research support from Biogen, Merck Serono and Novartis.